Skip to main content

Table 1 Baseline characteristics at inclusion

From: Effect of an analgo-sedation protocol for neurointensive patients: a two-phase interventional non-randomized pilot study

  Observational period
(n = 106)
Intervention period
(n = 109)
P Value
Male, n (%) 73 (69%) 65 (60%) .159
Female, n (%) 33 (31%) 44 (40%) .159
Age, mean years (SD) 55 (15) 52 (17) .100
Weight, mean kg (SD) 78 (14) 75 (16) .267
APACHE II, mean score (SD) 20 (4) 21 (5) .477
SAPS II, mean score (SD) 51 (10) 50 (11) .500
SOFA, mean score (SD) 8 (2) 8 (2) .707
Diagnosis, n (%)    .186
   SAH/ICH 50 (47%) 37 (34%)  
   SDH/TBI 37 (35%) 41 (38%)  
   Other 19 (18%) 30 (28%)  
  1. Sex and diagnosis (Chi-Square test); age, weight, APACHE II, SAPS II, SOFA (t-test); and P value ≤ .05 significant.
  2. ICH: intracerebral hemorrhage; SAH: subarachnoid hemorrhage; SDH: subdural hematoma; TBI: traumatic brain injury. Other: Medullar lesion, status epilepticus, neuromuscular disease, tumors, infections.